Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tilray Brands, Inc. TLRY

Alternate Symbol(s):  T.TLRY

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis business, Distribution business, Beverage alcohol business and Wellness business. The Cannabis business segment is engaged in the production, distribution, sale, co-manufacturing, and advisory services of both medical and adult-use cannabis. The Distribution business segment is focused on the purchase and resale of pharmaceutical products to customers. The Beverage alcohol business segment is engaged in the production, marketing and sale of beverage and beverage alcohol products. The Wellness business segment includes hemp foods and hemp-based cannabidiol (CBD) consumer products. The Company offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Bake Sale, XMG, Mollo, and others.


NDAQ:TLRY - Post by User

Comment by Oldweedon Feb 08, 2024 6:26pm
244 Views
Post# 35871243

RE:Tilray has reported inventory at or above

RE:Tilray has reported inventory at or above
Keeler wrote: $200 million for quite awhile on financials - along with inventory write downs/impairments in the millions as stale stock is destryed or de-valued (and dumped in the Israeli market)

Tilray also reported revenue of approx $70 million a quarter - so in effect, Tilray carries 3 years of inventory????

Geez oldweed - I guess you're lucky the product you got was only a year old, it must be popular.

One of the reasons Simon was finally (mercifully) terminated at Hain was because of his failed growth by acquisition strategy. Hain ended up with dozens of mis-kabolualted, misfit, non-profitable roganzaitions that couldn't possibly be integrated into a smooth running conglomerate - headed by over paid, incompetent seniro managment.

Lack of cost control, production efficiency - and NO synergies (otehr than staff layoffs).

Tilray is exactly the same model. 



Post by Oldweedon Feb 08, 2024 5:20pm
48 Views 
Post# 35871099

Unable to Fulfill Sales Not a Success Formula

So if sales are good , then you would expect to see from time to time a shortage of supply on the shelves, I beleive some have pointed out recently that is the case with drinks.. When I order CBD from Tilray I will receive product over a year old, cream or capsules doesn't matter its always old. I have tried the drinks, but again always limited supply on orders. If I look at chocalate, it's almost always out of stock. So what gives folks, if sales were hot the supply would not be old. There is something fundamentally wrong when the above conditions existed for months and and in some cases years. It's to the point now I will move the prescription over to OGI. If you consider that medical patients are a prioity then why would this even be an issue, again there is something very disfunctional with the management of production and distribution


Yep, quite something, I have run out of patience with them under Irwin, just appears to be so disorganized. Put Raj Grover in charge of this company's assets and it would have a chance to dominate the way HITI does. I can't phathom how they can possibly expand and supply the USA with what they are doing now. Regardless, I'm sure I'm am not the only patient that will have to find a new supply. Really is a shame what is going on here, 
<< Previous
Bullboard Posts
Next >>